Drug name - Gavreto

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US10030005 GENENTECH INC Inhibitors of RET
Nov, 2036

(14 years from now)

CN108473468B GENENTECH INC Inhibitors Of Ret
Nov, 2036

(14 years from now)

CN108473468A GENENTECH INC Inhibitors Of Ret
Nov, 2036

(14 years from now)

Drugs and Companies using PRALSETINIB ingredient

Treatment: NA

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
100MG CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.